Latest news articles

Added 6 days ago Drug news

Oncology Venture reports results of FDA meeting for dovitinib as a treatment for renal cell carcinoma.

Oncology Venture has had a meeting with the FDA to discuss a potential path to approval for dovitinib used to...

Added 1 month ago Drug news

Updated positive results for phase III CHECKMATE 214 study of Opdivo + Yervoy versus sunitinib to treat metastatic renal cell carcinoma. - BMS

-Bristol-Myers Squibb Company announced updated results from the Phase III CheckMate -214 study evaluating the combination of Opdivo (nivolumab) plus...

Added 1 month ago Drug news

Five year positive follow up of CHECKMATE 025 study of Opdivo versus everolimus for metastatic renal cell carcinoma .- BMS

Bristol-Myers Squibb Company announced five-year follow-up results from the Phase III CheckMate -025 study, which continue to demonstrate that treatment...

Search all news articles for Cancer of kidney and renal pelvis

Learning Zones

An Learning Zone (LZ) is an area of the site dedicated to providing detailed self-directed medical education about a disease, condition or procedure.

Hereditary ATTR amyloidosis

Hereditary ATTR amyloidosis

Explore the pathophysiology, epidemiology and multi-system symptoms associated with hereditary ATTR amyloidosis, as well as how to achieve an early and accurate diagnosis.

Fluid Management

Fluid Management

Are you up-to-date with the latest evidence of effective procedures for fluid management?

+ 2 more

Load more


Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Kidney cancer accounts for 5% and 3% of all adult malignancies in men and women, respectively, thus representing the 7th most common cancer in men and the 10th most common cancer in women.

Added 5 years ago

Guidelines on Renal Cell Carcinoma

The European Association of Urology (EAU) Renal Cell Cancer (RCC) Guidelines Panel has compiled these clinical guidelines to provide urologists with evidence-based information and recommendations for the management of renal cell cancer.

Added 4 years ago

Search all guidelines for Cancer of kidney and renal pelvis

Journal articles

Management of Adverse Events Associated with Cabozantinib Therapy in Renal Cell Carcinoma.

This review aims to provide appropriate guidance that will minimize the impact of adverse events and help to maximize the utility of this agent in patients with advanced renal cell carcinoma.

Added 1 year ago

Efficacy of tivozanib treatment after sorafenib in patients with advanced renal cell carcinoma: crossover of a phase 3 study.

Background: Tivozanib is a selective inhibitor of vascular endothelial growth factor receptors 1, 2 and 3 tyrosine kinases. This open-label, crossover clinical study (AV-951-09-902) provided access to tivozanib for patients...

Added 2 years ago

Tivozanib: a new treatment option for renal cell carcinoma.

Tivozanib is a tyrosine kinase inhibitor that targets all vascular endothelial growth factor receptors (VEGFRs), causing inhibition of angiogenesis. It has recently been approved by the European Medicines Agency (EMA)...

Added 2 years ago

Search all journal articles for Cancer of kidney and renal pelvis

Clinical trials

Cabozantinib Versus Sunitinib for Metastatic Variant Histology Renal Cell Carcinoma

The goal of this clinical research study is to compare the safety and effectiveness of cabozantinib and sunitinib when given to patients with metastatic (has spread) variant histology renal cell carcinoma (vhRCC), a type of kidney cancer.

Added 1 year ago

A Study of Atezolizumab in Combination With Bevacizumab Versus Sunitinib in Participants With Untreated Advanced Renal Cell Carcinoma [IMmotion151]

This multi-center, randomized, open-label study will evaluate the efficacy and safety of atezolizumab (MPDL3280A) plus bevacizumab versus sunitinib in participants with inoperable, locally advanced, or metastatic renal cell carcinoma (RCC)...

Added 2 years ago

Prospective Observational Analysis Of CR With Sunitinib Treatment In mRCC Patients (APERÇU)

This prospective study will investigate the characteristics of mRCC patients at time of CR in comparison with mRCC patients non on CR treated with Sunitinib...

Added 7 years ago

Search all clinical trials for Cancer of kidney and renal pelvis
Fiona Holland

Fiona worked in the fitness and wellness industry in the US for 13 years, supporting behaviour change in a variety of settings. Fiona’s research interests lie broadly within health and wellbeing. She is particularly interested in qualitative methodologies in the areas of body image ... Read more

What to say and do when someone has cancer

Ahead of World Cancer Day on Saturday (February 4), Fiona Holland, Psychology Lecturer, discusses what to say and what not to say to someone with cancer.